{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:18:14Z","timestamp":1758125894151},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81130088","81170219","81370245"],"award-info":[{"award-number":["81130088","81170219","81370245"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"973 Program Earlier Research Project","award":["(2012CB723505)"],"award-info":[{"award-number":["(2012CB723505)"]}]},{"name":"Graduate Student Innovative Scientific Research Program of Heilongjiang Province","award":["YJSCX2012-241HLJ"],"award-info":[{"award-number":["YJSCX2012-241HLJ"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.ejphar.2014.04.012","type":"journal-article","created":{"date-parts":[[2014,4,21]],"date-time":"2014-04-21T22:19:51Z","timestamp":1398118791000},"page":"202-210","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Cisapride protects against cardiac hypertrophy via inhibiting the up-regulation of calcineurin and NFATc-3"],"prefix":"10.1016","volume":"735","author":[{"given":"Xin","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaopeng","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaming","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Chege Gitau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenfeng","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoqian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.04.012_bib1","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0140-6736(95)90595-2","article-title":"Cisapride and torsades de pointes","volume":"345","author":"Ahmad","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2014.04.012_bib2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/archinte.1995.00430070125014","article-title":"Long QT syndrome during high-dose cisapride","volume":"155","author":"Bran","year":"1995","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ejphar.2014.04.012_bib3","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1093\/emboj\/19.23.6341","article-title":"The MEK1-ERK1\/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice","volume":"19","author":"Bueno","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.ejphar.2014.04.012_bib4","first-page":"303","article-title":"Inhibition of L-type Ca2+ current in guinea pig ventricular myocytes by cisapride","volume":"11","author":"Chiang","year":"2003","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ejphar.2014.04.012_bib5","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/S0092-8674(02)00699-2","article-title":"NFAT signaling: choreographing the social lives of cells","volume":"109","author":"Crabtree","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2014.04.012_bib6","doi-asserted-by":"crossref","first-page":"13571","DOI":"10.1074\/jbc.275.18.13571","article-title":"Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart. Cross-talk between cardiac hypertrophic signaling pathways","volume":"275","author":"De Windt","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2014.04.012_bib7","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/HYPERTENSIONAHA.109.139519","article-title":"Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy","volume":"55","author":"Dong","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2014.04.012_bib8","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/01.hjh.0000388492.73954.0b","article-title":"Novel regulators and drug targets of cardiac hypertrophy","volume":"28","author":"Finckenberg","year":"2010","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2014.04.012_bib9","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1097\/00029330-200712020-00018","article-title":"Chronic blocking of \u03b23-adrenoceptor ameliorates cardiac function in rat model of heart failure","volume":"120","author":"Gan","year":"2007","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.ejphar.2014.04.012_bib10","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/01.RES.0000018952.70505.F1","article-title":"Glycogen synthase kinase-3\u03b2 a novel regulator of cardiac hypertrophy and development","volume":"90","author":"Hardt","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2014.04.012_bib11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/1056-8719(94)90088-4","article-title":"Relationship between QT and RR intervals in rats, guinea pigs, rabbits, and primates","volume":"32","author":"Hayes","year":"1994","journal-title":"J. Pharmacol. Toxicol. Meth."},{"key":"10.1016\/j.ejphar.2014.04.012_bib12","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","article-title":"Regulation of cardiac hypertrophy by intracellular signalling pathways","volume":"7","author":"Heineke","year":"2006","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.ejphar.2014.04.012_bib13","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1056\/NEJM199910213411706","article-title":"Signaling pathways for cardiac hypertrophy and failure","volume":"341","author":"Hunter","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2014.04.012_bib14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF01955423","article-title":"Effects of pertussis toxin on alpha1- agonist-mediated phosphatidylinositide turnover and myocardial cell hypertrophy in neonatal rat ventricular myocytes","volume":"46","author":"Karliner","year":"1990","journal-title":"Experientia"},{"key":"10.1016\/j.ejphar.2014.04.012_bib15","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/00005344-199705000-00016","article-title":"Effects of 5-HT4-receptor agonists, cisapride, mosapride citrate, and zacopride, on cardiac action potentials in guinea pig isolated papillary muscles","volume":"29","author":"Kii","year":"1997","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.04.012_bib16","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1432-2277.2008.00742.x","article-title":"Mesenchymal stem cell transplantation attenuates cardiac fibrosis associated with isoproterenol-induced global heart failure","volume":"21","author":"Li","year":"2008","journal-title":"Transpl. Int."},{"key":"10.1016\/j.ejphar.2014.04.012_bib17","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/01.CIR.102.4.470","article-title":"Left ventricular hypertrophy: pathogenesis, detection, and prognosis","volume":"102","author":"Lorell","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2014.04.012_bib18","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/CIRCRESAHA.109.194035","article-title":"CaMK II negatively regulates calcineurin-NFAT signaling in cardiac myocyes","volume":"105","author":"MacDonnell","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2014.04.012_bib19","doi-asserted-by":"crossref","first-page":"F3","DOI":"10.1136\/fn.82.1.F3","article-title":"Should cisapride have been \u201cblacklisted\u201d?","volume":"82","author":"Markiewicz","year":"2000","journal-title":"Arch. Dis. Child. Fetal. Neonatal. Ed."},{"key":"10.1016\/j.ejphar.2014.04.012_bib20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cardiores.2004.01.021","article-title":"Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs","volume":"63","author":"Molkentin","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2014.04.012_bib21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0092-8674(00)81573-1","article-title":"A calcineurin-dependent transcriptional pathway for cardiac hypertrophy","volume":"93","author":"Molkentin","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2014.04.012_bib22","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/CIRCULATIONAHA.106.637124","article-title":"Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling","volume":"114","author":"Ni","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2014.04.012_bib23","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.cellsig.2010.03.015","article-title":"RGS2 inhibits \u03b2-adrenergic receptor-induced cardiomyocyte hypertrophy","volume":"22","author":"Nunn","year":"2010","journal-title":"Cell Signal"},{"key":"10.1016\/j.ejphar.2014.04.012_bib24","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1253\/circj.66.851","article-title":"Overexpression of endothelial nitric oxide synthase attenuates cardiac hypertrophy induced by chronic isoproterenol infusion","volume":"66","author":"Ozaki","year":"2002","journal-title":"Circ. J."},{"key":"10.1016\/j.ejphar.2014.04.012_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00210-009-0484-y","article-title":"Scutellarin exerts its anti-hypertrophic effects via suppressing the Ca2+-mediated calcineurin and CaMKII signaling pathways","volume":"381","author":"Pan","year":"2010","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.04.012_bib26","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1476-5381.1996.tb15295.x","article-title":"Cisapride-induced prolongation of cardiac action potential and early afterdepolarizations in rabbit Purkinje fibres","volume":"117","author":"Puisieux","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.04.012_bib27","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/01.RES.73.3.424","article-title":"Signal transduction pathways of angiotensin II-induced c-fos gene expression in cardiac myocytes in vitro. Roles of phospholipid-derived second messengers","volume":"73","author":"Sadoshima","year":"1993","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2014.04.012_bib28","first-page":"2173","article-title":"Increased expression of myocardial semaphorin 3A in isoproterenol-induced heart failure rats","volume":"124","author":"Sun","year":"2011","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.ejphar.2014.04.012_bib29","doi-asserted-by":"crossref","first-page":"383","DOI":"10.7150\/ijbs.7.383","article-title":"Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin\/NFATc3 pathway","volume":"7","author":"Tan","year":"2011","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejphar.2014.04.012_bib30","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nm1101-1236","article-title":"Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq\/Galpha11 in cardiomyocytes","volume":"7","author":"Wettschureck","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2014.04.012_bib31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2165\/00003495-199447010-00008","article-title":"Cisapride: an updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders","volume":"47","author":"Wiseman","year":"1994","journal-title":"Drugs"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914002969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914002969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T19:24:12Z","timestamp":1565378652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299914002969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":31,"alternative-id":["S0014299914002969"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.04.012","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cisapride protects against cardiac hypertrophy via inhibiting the up-regulation of calcineurin and NFATc-3","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}